Unicycive Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -34.5% | +973.7% | +9,088.2% | -85.0% | +403.6% | +123.2% | +55.2% | |
| – | -34.5% | +973.7% | +8,925.0% | -85.6% | +406.8% | +131.0% | +58.2% | |
| – | -40.0% | -100.0% | – | -97.3% | +2,032.1% | +169.5% | +11.7% | |
| – | -40.0% | – | – | -97.3% | +2,032.1% | +169.5% | +57.9% | |
| – | – | – | – | – | – | – | – | |
| – | -26.9% | +218.4% | -21.4% | +45.3% | +448.1% | +34.7% | -21.9% | |
| – | -26.9% | +218.4% | -26.8% | +56.0% | +433.9% | +37.6% | -21.5% | |
| – | -56.1% | +446.5% | -92.8% | +11.7% | +71.6% | +90.1% | -69.7% | |
| – | +436.7% | -42.9% | +303.3% | +14.0% | -3.0% | +17.7% | -68.8% | |
| – | – | – | – | -102.8% | – | – | +306.4% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -1.6% | +0.4% | +63.0% | +173.0% | +137.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.